Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes

by Rumiko Shimazawa, Masayuki Ikeda
Published 2019-11-01

Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus

by Masayuki Ikeda, Rumiko Shimazawa
Published 2019-07-01

Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)

by Rumiko Shimazawa, Masayuki Ikeda
Published 2021-05-01

Repression of Activated Aryl Hydrocarbon Receptor–Induced Transcriptional Activation by 5α-Dihydrotestosterone in Human Prostate Cancer LNCaP and Human Breast Cancer T47D Cells

by Noriko Sanada, Yuka Gotoh, Rumiko Shimazawa, Carolyn M. Klinge, Ryoichi Kizu
Published 2009-01-01